Why Health Insurance Needs Transparency W/ Ty Wang, Co-Founder & CEO, Angle Health
In this episode of CareTalk, Ty Wang, co‑founder and CEO of Angle Health, explains why he chose health insurance as the launchpad for his startup, citing the plan’s role as the central data and financing hub of American healthcare. He describes how Angle rebuilt the health‑plan stack on a modern, AI‑first infrastructure that unifies previously siloed systems, enabling real‑time cost transparency and custom plan designs for small and medium‑sized employers. By offering the same sophisticated services—specialty networks, care‑management programs, at‑home infusions—that large firms enjoy, Angle helps these businesses control costs and predict year‑over‑year premiums. Wang emphasizes that transparency, not just lower prices, is the key differentiator that empowers employers to budget and improve employee health outcomes.
How AI Is Shaping Biotech? Expert Insights From James Bilotta
In this episode of Biotech Bytes, SVP and Chief Digital Information Officer Jim Bellotta discusses how AI and digital transformation are reshaping biotech, emphasizing the shift of the CIO role from a back‑office tech function to a strategic business partner...
H-ISAC’s Englert Says Device Inventory and PHI Mapping Will Be the Heaviest Lifts When New HIPAA Drops
In this episode, Phil Englert, VP of Medical Device Security at Health‑ISAC, explains how the upcoming HIPAA security rule revisions will force healthcare organizations to undertake massive device inventories and map protected health information (PHI) flows across medical devices and...
Who’s Training Your Doctor? A Wake-Up Call on Medical Education
In this episode, Dr. Jennifer Hibbard, a pediatric dental surgeon and faculty member at the University of Toronto, critiques the rapid shift toward simulated, AI‑driven medical education and the loosening of traditional entry requirements in Canadian health schools. She highlights...
Why Hospitals Keep Defaulting to Medicare Logic
The episode explores why hospitals default to Medicare reimbursement logic when navigating the shift from fee‑for‑service to value‑based care. Host and guest compare the transition to crossing a precarious bridge, noting that mixed payment models create confusion and hinder the...
Beyond Senolytics: Senoadaptive Drugs & Clinical Data on GPX4 Modulation (Dr. Marco Quarta, Rubedo)
In this episode, Dr. Marco Quarta, co‑founder and CSO of Rubedo Life Sciences, discusses the company’s breakthrough first‑in‑class GPX4‑modulating drug RLS1496, which has just reported preliminary Phase 1 basket‑trial data across multiple skin indications. He explains how Rubedo’s AI‑enabled single‑cell multi‑omics...
Dr Louise Irvine: Setting up a Medical Advisory Network
Dr. Louise Irvine explains how she helped establish CanSG, a multidisciplinary clinical advisory network focused on sex‑related health issues, particularly the controversial use of puberty blockers and gender‑affirming treatments for youth. She outlines the group's origins in the UK, its...
Forget the Search for a Single AI ROI Number, Say Akhter and Chou — Build Coalitions, Scale What Works
In this episode, Children’s Hospital of Philadelphia’s SVP, Chief Digital and Information Officer Shaqib Octor and veteran health‑IT executive David Chow discuss how health systems are grappling with defining AI ROI. They argue that ROI isn’t just a dollar figure—it...
Scaling Scientific R&D with AI Supercomputing Infrastructure — with Thomas Fuchs of Eli Lilly
In this episode, Thomas Fuchs, Chief AI Officer at Eli Lilly, explains how the company is building an AI‑ready supercomputing platform—based on NVIDIA’s DGX SuperPod B300 architecture—to accelerate drug discovery, development, and manufacturing. He highlights that the massive compute power lets...
#392 - Genetic Testing: When It's Valuable, How to Choose the Right Test, and What to Do with the Results
In this episode, host Peter Atiyah demystifies genetic testing by outlining when it truly adds value, how to select the appropriate test, and how to act on the results. He explains that most genetic information is probabilistic, highlights the limits...
Part I: How Geotagged EVV Check-In Data Can Get Wired Into Medicaid and Medicare Managed Care Claim Edits to Reject...
The episode dissects the persistent fraud problem in home health agencies, highlighting how the recent CMS nationwide enrollment moratorium aims to curb new bad actors but does nothing for the roughly 11 agencies already in the system. It explains that...
The Real Purpose of Succession Planning in Healthcare Facilities
In this episode, host Peter Martin talks with Paul DeViller, Director of Plant Operations at Lahey Medical Center, and Ryan Gagnon, Assistant Director of Plant Operations, about the real purpose of succession planning in healthcare facilities. They emphasize that succession...
EP511: The Tension When Clinical Teams Take On Risk for Policymakers and Others Looking to Rustle Up Future Perverse Incentives,...
In this episode, Dr. Siva and Dr. Monica Lypson discuss the perverse incentives created when clinical teams assume financial risk in value‑based contracts, especially around upcoding, downcoding, and the resulting cherry‑picking or "lemon‑dropping" of patients. They argue that without transparent,...
304: JerryRigged Wheelchairs and More with Zack Nelson
In this episode, Sean and Matt interview Zach Nelson of Jerry Rigged Everything about his evolution from DIY Jeep repairs to building an affordable wheelchair business and other maker projects. Zach explains how his YouTube channel funds expensive manufacturing equipment,...
How Your Body Data Could Reshape Sectors
In this episode, Morgan Stanley health‑care analyst Erin Wright discusses the rise of the self‑directed patient, highlighting how direct‑to‑consumer lab tests and wearables are shifting health care from reactive treatment to proactive prevention. She notes that U.S. chronic disease costs...